Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center

BACKGROUND Heart failure and end-stage renal disease often coexist, and management of heart failure can be challenging in patients during hemodialysis. Sacubitril-valsartan (SV) is the first drug to receive regulatory approval for use in patients with chronic heart failure with reduced ejection frac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical science monitor 2024-07, Vol.30, p.e943529-e943529-10
Hauptverfasser:	Yao, Zhuan'e, Wang, Pengbo, Fu, Qinjuan, Song, Qiong, Liu, Ai, Li, Huan, Wang, Wei, Zhang, Peng
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aminobutyrates - adverse effects Aminobutyrates - pharmacology Aminobutyrates - therapeutic use Angiotensin Receptor Antagonists - adverse effects Angiotensin Receptor Antagonists - pharmacology Angiotensin Receptor Antagonists - therapeutic use Biphenyl Compounds - therapeutic use Chronic Disease Clinical Research Drug Combinations Female Heart Failure - drug therapy Heart Failure - physiopathology Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - physiopathology Kidney Failure, Chronic - therapy Male Middle Aged Quality of Life Renal Dialysis - methods Retrospective Studies Stroke Volume - drug effects Stroke Volume - physiology Tetrazoles - adverse effects Tetrazoles - pharmacology Tetrazoles - therapeutic use Treatment Outcome Valsartan - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!